XOMA Corp
NASDAQ:XOMA

  • LAST PRICE
    25.3600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    25.0000/ 1
  • Ask / Lots
    30.0000/ 1
  • Open / Previous Close
    25.5500 / 25.3600
  • Day Range
    25.2000
    26.7500
  • 52 Week Range
    13.4800
    27.0000
  • Volume
    6,783

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
XOMA
XOMA Corp
298.3M
-6.3x
---
OCGN
Ocugen Inc
303.6M
-4.5x
---
NBTX
Nanobiotix SA
279.1M
-3.3x
---
VTYX
Ventyx Biosciences Inc
298.6M
-1.2x
---
NAUT
Nautilus Biotechnology Inc
300.2M
-4.6x
---
GUTS
Fractyl Health Inc
301.2M
-3.4x
---
As of 2024-04-26

Company Information

XOMA Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Its royalty portfolio includes DAY101 (tovorafenib), JNJ-63723283 (cetrelimab), RZ358, arimoclomol, TAK-079 (mezagitamab), BAY-1213790 (osocimab), AFM13 (acimtamig), AB023 (gruticibart), AB002 (E-WE thrombin), AB054, AV-299 (ficlatuzumab), COM902, vosaroxin, aldoxorubicin, INCAGN2385, INCAGN02390, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, G03-52-01, RZ402, DSUVIA (sufentanil sublingual tablet), IXINITY [coagulation factor IX (recombinant)], VABYSMO (faricimab-svoa), CMP-001 (vidutolimod), and CFZ533 (iscalimab).

Contact Information

Headquarters
Suite 310, 2200 Powell StreetEMERYVILLE, CA, United States 94608
Phone
510-204-7239
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jack Wyszomierski
Chief Executive Officer, Director
Owen Hughes
Chief Financial Officer, Senior Vice President - Finance
Thomas Burns
Chief Investment Officer
Bradley Sitko
Independent Director
Heather Franklin

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$298.3M
Revenue (TTM)
$4.8M
Shares Outstanding
11.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.57
EPS
$-4.04
Book Value
$7.72
P/E Ratio
-6.3x
Price/Sales (TTM)
62.7
Price/Cash Flow (TTM)
---
Operating Margin
-879.53%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.